An ongoing revolution in healthcare ties data and reimbursement with the demand for analytics that provide insight into a variety of areas.
Changes are needed in the way scientific research is currently conducted to ensure its legitimacy and efficacy.
Explore the history and trace the development of BabyBIG, the life-saving immunotherapy for infant botulism.
Government and researchers continue to pursue plans and studies to gain a greater understanding of this devastating and deadly disease in order to prevent, treat and, ultimately, cure it.
Statin-triggered autoimmune myopathy can occur in rare instances where muscle-related symptoms fail to resolve following stoppage of the medication.
An exploratory controlled, randomized, double-blind study was conducted by investigators at the Sutter Neuroscience Institute in Sacramento to determine whether a single course of
intravenous immune globulin (IVIG) influences the rate of brain atrophy and cognitive function in mild cognitive impairment (MCI) due to Alzheimer’s disease (AD).
The growing number of strains of bacteria that are resistant to antibiotic treatment continues to plague patients and the healthcare community.
Seven case studies unveil some of the immunodeficiencies affecting seniors.
As biosimilars are introduced into the U.S. market, it remains to be seen whether FDA guidances will ensure their safety and efficacy.
IVIG has enhanced and even saved the lives of many autoimmune disease patients. But, the cost of therapy, large dose size and limited raw materials are serious limitations to an otherwise efficacious, well-tolerated therapy.
Current treatments for PANDAS have been shown to be relatively effective, but could surgical treatments such as tonsillectomy and adenoidectomy offer more effective results?
Still in its infancy, precision medicine holds out hope for moving directly from diagnosis to an effective tailor-fit treatment for each individual patient.